List of Excipients in API mifepristone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing mifepristone
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Corcept Therapeutics Incorporated | KORLYM | mifepristone | 76346-073 | ALUMINUM OXIDE | |
Corcept Therapeutics Incorporated | KORLYM | mifepristone | 76346-073 | CELLULOSE, MICROCRYSTALLINE | |
Corcept Therapeutics Incorporated | KORLYM | mifepristone | 76346-073 | D&C YELLOW NO. 10 | |
Corcept Therapeutics Incorporated | KORLYM | mifepristone | 76346-073 | FD&C YELLOW NO. 6 | |
Corcept Therapeutics Incorporated | KORLYM | mifepristone | 76346-073 | HYDROXYPROPYL CELLULOSE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing mifepristone
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 | CELLULOSE, MICROCRYSTALLINE |
Actavis Pharma Inc | mifepristone | 0591-4390 | FD&C BLUE NO. 1 |
Actavis Pharma Inc | mifepristone | 0591-4390 | FD&C YELLOW NO. 5 ALUMINUM LAKE |
Actavis Pharma Inc | mifepristone | 0591-4390 | FD&C YELLOW NO. 6 |
Actavis Pharma Inc | mifepristone | 0591-4390 | HYDROXYPROPYL CELLULOSE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for mifepristone
Excipient focus: ALUMINUM OXIDE
mifepristone drug variants containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
mifepristone drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
GenBioPro Inc | mifepristone | 43393-001 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
mifepristone drug variants containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
mifepristone drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5 ALUMINUM LAKE
mifepristone drug variants containing FD&C YELLOW NO. 5 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing FD&C YELLOW NO. 5 ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
mifepristone drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
mifepristone drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
mifepristone drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
mifepristone drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
mifepristone drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
GenBioPro Inc | mifepristone | 43393-001 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
mifepristone drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
mifepristone drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
mifepristone drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
mifepristone drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
mifepristone drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
mifepristone drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
mifepristone drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
mifepristone drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mifepristone | 0591-4390 |
Corcept Therapeutics Incorporated | mifepristone | 76346-073 |
Corcept Therapeutics Incorporated | mifepristone | 76346-654 |
>Company | >Ingredient | >NDC |
mifepristone drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
GenBioPro Inc | mifepristone | 43393-001 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.